US FDA grants GSK OK for 1st quad intramuscular flu vaccine
This article was originally published in Scrip
Executive Summary
British pharma giant GlaxoSmithKline won the US FDA's approval to market Fluarix Quadrivalent (influenza virus vaccine), the first intramuscular vaccine to cover against four influenza strains in adults and children as young as 3 years.